288
Participants
Start Date
August 31, 2008
Primary Completion Date
April 30, 2009
Study Completion Date
April 30, 2009
Alogliptin and metformin
Alogliptin 12.5 mg, tablets, orally, once daily and metformin 250 mg, tablets, orally, twice or three times daily for up 12 weeks.
Alogliptin and metformin
Alogliptin 25 mg, tablets, orally, once daily and metformin 250 mg, tablets, orally, twice or three times daily for up 12 weeks.
Metformin
Metformin 250 mg, tablets, orally, twice or three times daily and alogliptin placebo-matching tablets, orally, once daily for up 12 weeks.
Lead Sponsor
Takeda
INDUSTRY